Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gladskin (Staphefekt) for skin symptoms in adults with Netherton syndrome
NL-OMON26178Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2019
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Staphefekt in Netherton syndrome (NS), sponsored by Erasmus MC. Primary endpoint: Patient Global Assessment. Started Jan 2019; status: recruiting.
02
Drugs
Staphefekt
03
Conditions
Netherton syndrome (NS)
Beyond the preview
Go deeper on NL-OMON26178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26178.